Trevi Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 17.3%.

Top 25 shareholders own 75.53% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
16.1%	New Enterprise Associates, Inc.	11,370,376	US$34.3m	0%	1.82%
10.5%	Frazier Life Sciences Management, LP	7,381,090	US$22.3m	7.27%	0.88%
8.07%	Rubric Capital Management LP	5,684,420	US$17.2m	0%	0.53%
6.25%	Viking Global Investors LP	4,400,000	US$13.3m	0%	0.05%
4.86%	VR Adviser, LLC	3,422,397	US$10.3m	0%	0.53%
4.47%	Armistice Capital LLC	3,147,200	US$9.5m	0%	0.23%
3.6%	Opaleye Management Inc.	2,535,000	US$7.7m	48.6%	1.79%
3.29%	BlackRock, Inc.	2,319,716	US$7.0m	7.98%	no data
3.19%	The Vanguard Group, Inc.	2,243,399	US$6.8m	14.6%	no data
1.83%	Checkpoint Capital, LLC, Asset Management Arm	1,292,316	US$3.9m	0%	2.75%
1.82%	MAI Capital Management, LLC	1,279,458	US$3.9m	-11.9%	0.05%
1.8%	Tejara Capital Limited., Asset Management Arm	1,269,000	US$3.8m	604%	1.42%
1.31%	Rosalind Advisors, Inc.	926,016	US$2.8m	-50.3%	2.39%
1.29%	Landscape Capital Management, LLC	910,094	US$2.7m	0%	0.23%
1.23%	Silverarc Capital Management, LLC	863,883	US$2.6m	-6.85%	0.71%
1.21%	Geode Capital Management, LLC	849,881	US$2.6m	7.9%	no data
1.05%	State Street Global Advisors, Inc.	741,193	US$2.2m	4.6%	no data
0.77%	Renaissance Technologies LLC	542,700	US$1.6m	706%	no data
0.6%	Anson Group	420,803	US$1.3m	0%	0.19%
0.5%	David Meeker	352,489	US$1.1m	0%	no data
0.45%	Northern Trust Global Investments	314,178	US$948.8k	-0.44%	no data
0.43%	Tang Capital Management, LLC	300,000	US$906.0k	0%	0.09%
0.3%	Jennifer Good	213,313	US$644.2k	0.9%	no data
0.3%	Bridgeway Capital Management, LLC	211,481	US$638.7k	13.4%	0.01%
0.3%	Thomas Sciascia	208,447	US$629.5k	1.85%	no data